| 
																	
																		 
																		 Adrenergic Agonists
 
																		 
																		
																	 
																		 
																		
																	 
																			
																					
	"Adrenergic Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				Drugs that bind to and activate adrenergic receptors.
    
			 
				
				
					
						| Descriptor ID | D000322 |  
						| MeSH Number(s) | D27.505.519.625.050.100 D27.505.696.577.050.100 |  
						| Concept/Terms | Adrenergic AgonistsAdrenergic AgonistsAgonists, AdrenergicReceptor Agonists, AdrenergicAdrenomimeticsAdrenergic AgonistAgonist, AdrenergicAdrenergic Receptor AgonistsAgonists, Adrenergic ReceptorAdrenergic Receptor AgonistAgonist, Adrenergic ReceptorReceptor Agonist, Adrenergic
 |  
				Below are MeSH descriptors whose meaning is more general than "Adrenergic Agonists". 
				Below are MeSH descriptors whose meaning is more specific than "Adrenergic Agonists". 
	
	
		
			
			
					
				This graph shows the total number of publications written about "Adrenergic Agonists" by people in this website by year, and whether "Adrenergic Agonists" was a major or minor topic of these publications.  
					  To see the data from this visualization as text, click here. 
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 2005 | 0 | 1 | 1 |  | 2008 | 0 | 1 | 1 |  | 2010 | 1 | 0 | 1 |  | 2018 | 1 | 0 | 1 | 
 
                    To return to the timeline, click here. 
				Below are the most recent publications written about "Adrenergic Agonists" by people in Profiles. 		
					
								
								Loe IM, Blum NJ, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, Friedman S, LaRosa A, Mittal S, Vanderbilt D, Harstad E. Adverse Effects of a-2 Adrenergic Agonists and Stimulants in Preschool-age Attention-deficit/Hyperactivity Disorder: A Developmental-Behavioral Pediatrics Research Network Study. J Pediatr. 2023 06; 257:113325.
								Judenherc-HaouzI A, Sonobe T, Bebarta VS, Haouzi P. On the Efficacy of Cardio-Pulmonary Resuscitation and Epinephrine Following Cyanide- and H2S Intoxication-Induced Cardiac Asystole. Cardiovasc Toxicol. 2018 10; 18(5):436-449.
								Gross CA, Bowler RP, Green RM, Weinberger AR, Schnell C, Chu HW. beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells. BMC Pulm Med. 2010 May 14; 10:30.
								Greenhawt MJ, McMorris MS, Furlong TJ. Self-reported allergic reactions to peanut and tree nuts occurring on commercial airlines. J Allergy Clin Immunol. 2009 Sep; 124(3):598-9.
								Balter M, Ernst P, Watson W, Kim H, Cicutto L, Beauchesne MF, Cave AJ, Kaplan A, Hogg D, McIvor A, Smiley T, Rouleau M, FitzGerald JM. Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J. 2008 Nov-Dec; 15 Suppl B:1B-19B.
								Wiener ES, Bajaj L. Diagnosis and emergent management of anaphylaxis in children. Adv Pediatr. 2005; 52:195-206.
								Kapoor JR, Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci. 2000 Dec 01; 20(23):8868-75.
								Henson PM, Oades ZG. Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion. J Exp Med. 1976 Apr 01; 143(4):953-68. | 
																	
																		
																			
																					People  People who have written about this concept._ 
    
        Similar Concepts   
        People who have written about this concept.
     _ 
    
        Top Journals   
        Top journals in which articles about this concept have been published.
     |